Form 4: Bio-Key International Director Acquires Shares Through Stock Incentive Plan

Robert J. Michel, a director at Bio-Key International, acquired shares of common stock through the company's 2023 Stock Incentive Plan and board committee meeting attendance fees.

Summary

• On July 31, 2024, Robert J. Michel, a director of Bio-Key International, acquired 3,500 shares of common stock as restricted stock under the company's 2023 Stock Incentive Plan.
• These shares vest in three equal annual installments, contingent upon continued service to the Issuer.
• Additionally, Michel acquired 676 shares of common stock in payment of board committee meeting attendance fees.
• Following these transactions, Michel's total holdings increased to 7,848 shares, excluding options to purchase 47 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects routine stock transactions by a company director. It doesn't indicate any significant positive or negative developments for the company.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The stock incentive plan aligns the director's interests with those of the shareholders.

Industry Context

This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Key Dates

Keywords

Bio-Key International, Director, Stock Incentive Plan, Share Acquisition, Form 4, BKYI, Robert J. Michel